Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer

NCT06569459 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Trilaciclib Injection [Cosela]
DRUG: Placebo

Sponsor

The First Affiliated Hospital with Nanjing Medical University